REHOVOT, Israel and BRIDGEWATER, N.J., April 1, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing its proprietary topical foams to address unmet needs in dermatology, today announced it has filed a registration statement with the Securities and Exchange Commission (SEC) for a proposed public offering of its ordinary shares. All of the shares will be offered by the company.
SOMERSET, N.J., April 1, 2015 (GLOBE NEWSWIRE) -- MTBC (Nasdaq:MTBC), a leading provider of proprietary, web-based electronic health records, practice management and mHealth solutions, today announced its spring educational webinar series to be delivered by Laila Qasim Esq., Client Advocate and Associate General Counsel.
DENVER, April 1, 2015 (GLOBE NEWSWIRE) -- PDC Energy, Inc. ("PDC" or the "Company") (Nasdaq:PDCE) today announced plans to host a conference call with investors to discuss first quarter 2015 results. Conference call materials will be available on the Company's website, www.pdce.com, at the time of the call.
NEW YORK, April 1, 2015 (GLOBE NEWSWIRE) -- Labaton Sucharow LLP ("Labaton Sucharow") filed a securities class action lawsuit on April 1, 2015 in the U.S. District Court for the Southern District of New York. The lawsuit was filed on behalf of all persons or entities who, between January 22, 2014 and October 17, 2014, inclusive (the "Class Period"), purchased or otherwise acquired the publicly traded securities of International Business Machines Corporation ("IBM" or the "Company") (NYSE:IBM).
PALO ALTO, Calif., April 1, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced successful completion of a planned interim analysis of its STOP-HE study, a double-blind placebo-controlled study of OCR-002 in patients with acute hepatic encephalopathy (HE). The study's independent Data Monitoring Committee (DMC) reported that the trial is not futile and no drug-related safety signals have been observed in the study. Based on the DMC's recommendation, Ocera will continue the STOP-HE study and will increase target enrollment from 140 patients to approximately 230 patients. The Company remains blinded to data reviewed by the DMC in the interim analysis.
SCOTTSDALE, Ariz., April 1, 2015 (GLOBE NEWSWIRE) -- Spirit Realty Capital, Inc. (NYSE:SRC) ("Spirit"), a real estate investment trust (REIT) that invests in single-tenant, operationally essential real estate, today announced that it has closed a $600 million unsecured credit facility, which initially bears interest at LIBOR plus 170 basis points. The new facility replaces Spirit's previous $400 million facility, which most recently bore interest at LIBOR plus 250 basis points, and improves the borrowing terms as well as the interest rate.
CONWAY, Ark., April 1, 2015 (GLOBE NEWSWIRE) -- Home BancShares, Inc. (Nasdaq:HOMB) ("Home" or "the Company"), parent company of Centennial Bank ("Centennial"), announced today the completion of an acquisition of national commercial real estate loans from J.C. Flowers & Co. LLC totaling approximately $289.1 million. This pool of loans was originated within the former Doral Property Finance portfolio and will now be housed in a division of Centennial known as the Centennial Commercial Finance Group ("Centennial CFG"). The Centennial CFG will be responsible for servicing the acquired loan pool and originating new loan production. The transaction is expected to be immediately accretive to earnings.
GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.